 Home > Active Ingredient News > Blood System > Lancet: Supports the use of platelet function or genetic testing to optimize drug choices for PCI patients

Lancet: Supports the use of platelet function or genetic testing to optimize drug choices for PCI patients

 Last Update: 2021-04-22
 Source: Internet
 Author: User

Tags

automated data analysis

study hormones

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Dual antiplatelet therapy is a standard care program for thrombosis prevention in patients undergoing percutaneous coronary intervention (PCI) .

Thrombosis prevention

Recently, researchers compared the safety and effectiveness of standard antiplatelet therapy versus selective guidance programs in PCI patients.

This study is a systematic review and meta-analysis.

medsci.

Studies believe that compared with the standard clopidogrel prevention program, the selection of antiplatelet therapy based on the characteristics of hepatocyte cytochrome p4502c19 gene after PCI can improve the efficacy, improve safety, and reduce the risk of small bleeding.

Compared with the standard clopidogrel prevention program, selection of antiplatelet therapy based on the characteristics of hepatic cytochrome p4502c19 gene after PCI can improve the efficacy, improve safety, and reduce the risk of minor bleeding.

Original source:

Mattia Galli et al.

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Dextran powder

CAS No.: 9004-54-0

Pharmacy Grade

$1-1.2/KG FOB

Dextran iron powder

CAS No.: 9004-66-4

Pharmacy Grade

$1-1.3/KG FOB

Clopidogrel

CAS No.: 113665-84-2

Industrial Grade / pharmaceutical grade

$1/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.